| [1] |
Hurley JB. Retina metabolism and metabolism in the pigmented epithelium: a busy intersection[J]. Annu Rev Vis Sci, 2021, 7(1): 665-692.
|
| [2] |
Weill Y, Brosh K, Levi VT, et al. Enhanced depth imaging in swept-source optical coherence tomography: improving visibility of choroid and sclera, a masked study[J]. Eur J Ophthalmol, 2020, 30(6): 1295-1300.
|
| [3] |
Alizadeh ER, Mahdad E, Alireza P, et al. An update on choroidal layer segmentation methods in optical coherence tomography images: a review[J]. J Biomed Phys Eng, 2022, 12(1): 1-20.
|
| [4] |
Kim YH, Togloom A, Oh J. Correlation between hyperreflective foci in the choroid and choroidal discoloration in Vogt-Koyanagi-Harada disease[J]. Invest Ophthalmol Vis Sci, 2022, 63(9): 27-35.
|
| [5] |
Huang CH, Yang CH, Lai YJ, et al. Hyperreflective foci as important prognostic indicators of progression of retinitis pigmentosa[J]. Retina, 2022, 42(2): 388-395.
|
| [6] |
Roy R, Saurabh K, Shah D, et al. Choroidal hyperreflective foci: a novel spectral domain optical coherence tomography biomarker in eyes with diabetic macular edema[J]. Asia Pac J Ophthalmol (Phila), 2019, 8(4): 314-318.
|
| [7] |
Chhablani J, Hanumunthadu D, Matet A, et al. Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy[J]. Indian J Ophthalmol, 2019, 67(11): 1850-1855.
|
| [8] |
Battaglia PM, Sacconi R, Romano F, et al. Hyperreflective foci in Stargardt disease: 1-year follow-up[J]. Graefes Arch Clin Exp Ophthalmol, 2019, 257(1): 41-48.
|
| [9] |
Ulla L, Foti C, Arrigo A, et al. Choroidal hyperreflective foci represent a common finding across different types of macular atrophy[J]. Invest Ophthalmol Vis Sci, 2025, 66(6): 42-48.
|
| [10] |
Hsia Y, Yang CH, Hsieh YT, et al. Hyperreflective foci in predicting the treatment outcome of antivascular endothelial growth factor in neovascular age-related macular degeneration[J]. Graefes Arch Clin Exp Ophthalmol, 2020, 258(2): 273-280.
|
| [11] |
Midena G, Danieli L, Pilotto E, et al. Hyperreflective choroidal foci in diabetic eyes with and without macular edema: novel insights on diabetic choroidopathy[J]. Exp Eye Res, 2024, 247: 110020.
|
| [12] |
Ípek ʂ C, Ayhan Z, Kadayıfçılar S, et al. Swept-source optical coherence tomography angiography in a patient with Bietti crystalline dystrophy followed for ten years[J]. Turk J Ophthalmol, 2019, 49(2): 106-108.
|
| [13] |
Kim YH, Oh J. Hyperreflective foci in the choroid of normal eyes[J]. Graefes Arch Clin Exp Ophthalmol, 2022, 260(3): 759-769.
|
| [14] |
Song MS, Kim YH, Oh J. Spatial distribution of hyperreflective choroidal foci in the macula of normal eyes[J]. Transl Vis Sci Technol, 2024, 13(8): 35-41.
|
| [15] |
Félix R, Gouveia N, Bernardes J, et al. Prognostic impact of hyperreflective foci in nonsyndromic retinitis pigmentosa[J]. Graefes Arch Clin Exp Ophthalmol, 2024, 262(9): 2851-2858.
|
| [16] |
Arrigo A, Amato A, Barresi C, et al. Choroidal modifications preceding the onset of macular neovascularization in age-related macular degeneration[J]. Ophthalmol Ther, 2022, 11(1): 377-386.
|
| [17] |
Nassisi M, Fan W, Shi Y, et al. Quantity of intraretinal hyperreflective foci in patients with intermediate age-related macular degeneration correlates with 1-year progression[J]. Invest Ophthalmol Vis Sci, 2018, 59(8): 3431-3437.
|
| [18] |
Saurabh K, Roy R, Herekar S, et al. Validation of choroidal hyperreflective foci in diabetic macular edema through a retrospective pilot study[J]. Indian J Ophthalmol, 2021, 69(11): 3203-3206.
|
| [19] |
Nanji K, Grad J, Hatamnejad A, et al. Baseline optical coherence tomography biomarkers associated with visual acuity in diabetic macular edema: a systematic review and meta-analysis[J]. Ophthalmology, 2025: S016164202500483X.
|
| [20] |
Markan A, Agarwal A, Arora A, et al. Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema[J]. Ther Adv Ophthalmol, 2020, 12: 2515841420950513.
|
| [21] |
Kang JW, Chung H, Chan KH. Correlation of optical coherence tomographic hyperreflective foci with visual outcomes in different patterns of diabetic macular edema[J]. Retina, 2016, 36(9): 1630-1639.
|
| [22] |
Hwang HS, Chae JB, Kim JY, et al. Association between hyperreflective dots on spectral-domain optical coherence tomography in macular edema and response to treatment[J]. Invest Ophthalmol Vis Sci, 2017, 58(13): 5958-5963.
|
| [23] |
Schreur V, Altay L, Van AF, et al. Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema[J]. PLoS One, 2018, 13(10): e0206482.
|
| [24] |
Arrigo A, Capone L, Lattanzio R, et al. Optical coherence tomography biomarkers of inflammation in diabetic macular edema treated by fluocinolone acetonide intravitreal drug-delivery system implant[J]. Ophthalmol Ther, 2020, 9(4): 971-980.
|
| [25] |
Kim M, Lee JH, Suh H, et al. Hyperreflective choroidal foci and their longitudinal changes following treatment for branched retinal vein occlusion-associated macular edema[J]. Retina, 2026: 1-24.
|
| [26] |
Borrelli E, Reibaldi M, Barresi C, et al. Choroidal hyperreflective foci in geographic atrophy[J]. Invest Ophthalmol Vis Sci, 2023, 64(14): 5-9.
|
| [27] |
Arrigo A, Calamuneri A, Aragona E, et al. OCTA-based identification of different vascular patterns in Stargardt disease[J]. Transl Vis Sci Technol, 2019, 8(6): 26-31.
|
| [28] |
Lee SY, Yoon CK, Park UC, et al. Choroidal hyperreflective foci as biomarkers of severity in Stargardt disease[J]. Retina, 2025, 45(4): 774-784.
|
| [29] |
Arrigo A, Calamuneri A, Aragona E, et al. Structural OCT parameters associated with treatment response and macular neovascularization onset in central serous chorioretinopathy[J]. Ophthalmol Ther, 2021, 10(2): 289-298.
|
| [30] |
Hwang BE, Kim JY, Kim RY, et al. En-face optical coherence tomography hyperreflective foci of choriocapillaris in central serous chorioretinopathy[J]. Sci Rep, 2023, 13(1): 7184-7190.
|
| [31] |
Jorge RM, Marco P, Matteo G, et al. Choroidal characteristics of acute and chronic central serous chorioretinopathy using enhanced depth imaging optical coherence tomography[J]. Eur J Ophthalmol, 2017, 27(4): 476-480.
|
| [32] |
Chhablani J, Hanumunthadu D, Rasheed M, et al. Choroidal hyperreflective foci and vascularity in retinal dystrophy[J]. Indian J Ophthalmol, 2020, 68(1): 130-136.
|
| [33] |
何桂琴，文峰。正常眼的脉络膜血管系统研究进展[J]. 眼科学报，2024, 39(7)：365-373.
|
| [34] |
Agrawal R, Arora R, Keane PA, et al. Morphometric features on enhanced depth imaging optical coherence tomography scans in idiopathic posterior uveitis or panuveitis[J]. Int Ophthalmol, 2018, 38(3): 993-1002.
|
| [35] |
Cideciyan AV, Aleman TS, Swider M, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence[J]. Hum Mol Genet, 2004, 13(5): 525-534.
|
| [36] |
Romano F, Arrigo A, MacLaren RE, et al. Hyperreflective foci as a pathogenetic biomarker in choroideremia[J]. Retina, 2020, 40(8): 1634-1640.
|
| [37] |
Davis JL. Intraocular lymphoma: a clinical perspective[J]. Eye, 2013, 27(2): 153-162.
|
| [38] |
Menean M, Apuzzo A, Mastaglio S, et al. Imaging biomarkers of leukaemic choroidopathy[J]. Acta Ophthalmol, 2023, 101(5): 553-559.
|
| [39] |
Silpa-archa S, Silpa-archa N, Preble JM, et al. Vogt-Koyanagi-Harada syndrome: perspectives for immunogenetics, multimodal imaging, and therapeutic options[J]. Autoimmun Rev, 2016, 15(8): 809-819.
|
| [40] |
Lima LH, De Andrade GC, Vianello S, et al. Multimodal imaging analyses of hyperreflective dot-like lesions in acute syphilitic posterior placoid chorioretinopathy[J]. J Ophthalmic Inflamm Infect, 2017, 7(1): 1-6.
|
| [41] |
Crist AJ. Case report: choriocapillaris flow voids in acute syphilitic posterior placoid chorioretinitis[J]. Ocul Immunol Inflamm, 2022, 99(10): 774-780.
|
| [42] |
Pichi F, Ciardella AP, Cunningham ET, et al. Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy[J]. Retina, 2014, 34(2): 373-384.
|